| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 12206935
[patent_doc_number] => 20180052161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-22
[patent_title] => 'BIOMARKERS FOR MALARIA DIAGNOSIS'
[patent_app_type] => utility
[patent_app_number] => 15/558545
[patent_app_country] => US
[patent_app_date] => 2016-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 12352
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15558545
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/558545 | BIOMARKERS FOR MALARIA DIAGNOSIS | Mar 15, 2016 | Abandoned |
Array
(
[id] => 14040823
[patent_doc_number] => 20190076518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => Composition for Oral or Nasal Delivery of Tetanus, Diphtheria, and Pertussis Vaccine alone or in combination using Neurotoxin Associated Proteins
[patent_app_type] => utility
[patent_app_number] => 15/064651
[patent_app_country] => US
[patent_app_date] => 2016-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6230
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15064651
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/064651 | Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins | Mar 8, 2016 | Issued |
Array
(
[id] => 11642203
[patent_doc_number] => 09663559
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-30
[patent_title] => 'Chromatography ligand comprising domain C from Staphylococcus aureus protein A for antibody isolation'
[patent_app_type] => utility
[patent_app_number] => 15/063471
[patent_app_country] => US
[patent_app_date] => 2016-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7418
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15063471
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/063471 | Chromatography ligand comprising domain C from Staphylococcus aureus protein A for antibody isolation | Mar 6, 2016 | Issued |
Array
(
[id] => 11053352
[patent_doc_number] => 20160250314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'COMPOSITIONS AND METHODS FOR DETECTING, TREATING, AND PROTECTING AGAINST FUSOBACTERIUM INFECTION'
[patent_app_type] => utility
[patent_app_number] => 15/052594
[patent_app_country] => US
[patent_app_date] => 2016-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 22695
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15052594
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/052594 | Compositions and methods for detecting, treating, and protecting against Fusobacterium infection | Feb 23, 2016 | Issued |
Array
(
[id] => 11560517
[patent_doc_number] => 09623076
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-18
[patent_title] => 'Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use'
[patent_app_type] => utility
[patent_app_number] => 15/043740
[patent_app_country] => US
[patent_app_date] => 2016-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 25311
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 1129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15043740
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/043740 | Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use | Feb 14, 2016 | Issued |
Array
(
[id] => 10996383
[patent_doc_number] => 20160193330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'COMPOSITIONS OF VACCINES AND ADJUVANTS AND METHODS FOR THE TREATMENT OF URINARY TRACT INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 15/043452
[patent_app_country] => US
[patent_app_date] => 2016-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22156
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15043452
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/043452 | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections | Feb 11, 2016 | Issued |
Array
(
[id] => 11915405
[patent_doc_number] => 09783583
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-10
[patent_title] => 'Antigenic polypeptides of Trichinella and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 15/008863
[patent_app_country] => US
[patent_app_date] => 2016-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 6652
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15008863
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/008863 | Antigenic polypeptides of Trichinella and uses thereof | Jan 27, 2016 | Issued |
Array
(
[id] => 12118820
[patent_doc_number] => 20180002407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'IMMUNOLOGICAL DETECTION METHOD AND KIT FOR MYCOPLASMA PNEUMONIAE'
[patent_app_type] => utility
[patent_app_number] => 15/547299
[patent_app_country] => US
[patent_app_date] => 2016-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8168
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15547299
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/547299 | IMMUNOLOGICAL DETECTION METHOD AND KIT FOR MYCOPLASMA PNEUMONIAE | Jan 26, 2016 | Abandoned |
Array
(
[id] => 10774815
[patent_doc_number] => 20160120971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'IMMUNOGENIC COMPOSITION COMPRISING NEISSERIA MENINGITIDIS MACROPHAGE INFECTIVITY POTENTIATOR PROTEIN AND METHODS FOR USING THEM'
[patent_app_type] => utility
[patent_app_number] => 14/983407
[patent_app_country] => US
[patent_app_date] => 2015-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9512
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14983407
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/983407 | IMMUNOGENIC COMPOSITION COMPRISING NEISSERIA MENINGITIDIS MACROPHAGE INFECTIVITY POTENTIATOR PROTEIN AND METHODS FOR USING THEM | Dec 28, 2015 | Abandoned |
Array
(
[id] => 13687509
[patent_doc_number] => 20170354709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
[patent_app_type] => utility
[patent_app_number] => 15/539380
[patent_app_country] => US
[patent_app_date] => 2015-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8466
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539380
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/539380 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Dec 22, 2015 | Abandoned |
Array
(
[id] => 10981682
[patent_doc_number] => 20160178627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'System and Method for Identification and Characterization of Transglutaminase Species'
[patent_app_type] => utility
[patent_app_number] => 14/973472
[patent_app_country] => US
[patent_app_date] => 2015-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 17118
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14973472
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/973472 | System and method for identification and characterization of transglutaminase species | Dec 16, 2015 | Issued |
Array
(
[id] => 12975919
[patent_doc_number] => 20170340723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => Process for Ready-to-Use PCV2/M.HYO Combination Vaccine
[patent_app_type] => utility
[patent_app_number] => 15/534232
[patent_app_country] => US
[patent_app_date] => 2015-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18379
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15534232
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/534232 | Process for ready-to-use PCV/M.Hyo combination vaccine | Dec 9, 2015 | Issued |
Array
(
[id] => 10735946
[patent_doc_number] => 20160082096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-24
[patent_title] => 'VACCINE AGAINST STREPTOCOCCAL INFECTIONS BASED ON RECOMBINANT PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/959672
[patent_app_country] => US
[patent_app_date] => 2015-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11715
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14959672
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/959672 | Vaccine against streptococcal infections based on recombinant proteins | Dec 3, 2015 | Issued |
Array
(
[id] => 11183694
[patent_doc_number] => 09415079
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-16
[patent_title] => 'Composition for inducing proliferation or accumulation of regulatory T cells'
[patent_app_type] => utility
[patent_app_number] => 14/955532
[patent_app_country] => US
[patent_app_date] => 2015-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 53
[patent_no_of_words] => 23058
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14955532
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/955532 | Composition for inducing proliferation or accumulation of regulatory T cells | Nov 30, 2015 | Issued |
Array
(
[id] => 13812541
[patent_doc_number] => 10183028
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-22
[patent_title] => Enrichment method of ergosterol peroxide from sporoderm-broken
[patent_app_type] => utility
[patent_app_number] => 15/526682
[patent_app_country] => US
[patent_app_date] => 2015-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4053
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 237
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15526682
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/526682 | Enrichment method of ergosterol peroxide from sporoderm-broken | Nov 30, 2015 | Issued |
Array
(
[id] => 10805273
[patent_doc_number] => 20160151430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/955630
[patent_app_country] => US
[patent_app_date] => 2015-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 23054
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14955630
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/955630 | Composition for inducing proliferation or accumulation of regulatory T cells | Nov 30, 2015 | Issued |
Array
(
[id] => 11217796
[patent_doc_number] => 09446115
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-20
[patent_title] => 'Methods of stimulating immunity employing dengue viral antigens'
[patent_app_type] => utility
[patent_app_number] => 14/955691
[patent_app_country] => US
[patent_app_date] => 2015-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 89
[patent_figures_cnt] => 93
[patent_no_of_words] => 32238
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14955691
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/955691 | Methods of stimulating immunity employing dengue viral antigens | Nov 30, 2015 | Issued |
Array
(
[id] => 10805318
[patent_doc_number] => 20160151475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'Bacterial Ribonucleic Acid Cell Wall Compositions and Methods of Making and Using Them'
[patent_app_type] => utility
[patent_app_number] => 14/953700
[patent_app_country] => US
[patent_app_date] => 2015-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 43932
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14953700
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/953700 | Bacterial Ribonucleic Acid Cell Wall Compositions and Methods of Making and Using Them | Nov 29, 2015 | Abandoned |
Array
(
[id] => 10728356
[patent_doc_number] => 20160074505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'Method and System for Targeting the Microbiome to Promote Health and Treat Allergic and Inflammatory Diseases'
[patent_app_type] => utility
[patent_app_number] => 14/954074
[patent_app_country] => US
[patent_app_date] => 2015-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 45637
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14954074
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/954074 | Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases | Nov 29, 2015 | Issued |
Array
(
[id] => 10728347
[patent_doc_number] => 20160074495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-17
[patent_title] => 'Inactivated Bacterial Cell Formulation'
[patent_app_type] => utility
[patent_app_number] => 14/949362
[patent_app_country] => US
[patent_app_date] => 2015-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 13863
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14949362
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/949362 | Inactivated bacterial cell formulation | Nov 22, 2015 | Issued |